Precision Biosensor

Precision Biosensor Inventory Turnover

The Inventory Turnover Ratio of Precision Biosensor (335810.KQ) as of Oct 28, 2026 is 1.52. In the previous year, Inventory Turnover Ratio was 1.04 — a change of 46.22% (higher).

Inventory Turnover

1.52

YoY

46.22%

Last updated:

Inventory Turnover Ratio of Precision Biosensor is 2025 1.52 . Inventory Turnover Ratio of Precision Biosensor was 2024 1.04 . It decreases by 46.22% higher compared to the previous year.

The Precision Biosensor Inventory Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory Turnover
Date
Inventory Turnover
Jan 1, 2018
1.37 KRW
Jan 1, 2019
1.84 KRW
Jan 1, 2020
0.83 KRW
Jan 1, 2021
1.50 KRW
Jan 1, 2022
1.42 KRW
Jan 1, 2023
1.04 KRW
Jan 1, 2024
1.04 KRW
Jan 1, 2025
1.52 KRW
The Precision Biosensor Inventory Turnover history
YEARInventory TurnoverYoY
1.52+46.22%
1.04+0.54%
1.04-27.17%
1.42-5.20%
1.50+79.63%
0.83-54.66%
1.84+34.85%
1.37+10.37%
1.24—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Precision Biosensor Stock analysis

What does Precision Biosensor do? Precision Biosensor Inc. generates revenue through the sale of portable immunoassay diagnostic devices and cartridges. The testers, which are portable devices using colorimetric and time-resolved fluorescence, are sold for on-site diagnosis of acute heart disease, metabolism, and inflammatory diseases. The cartridges, designed for gold absorption and time-resolved fluorescence analysis, are used in diagnostic equipment to check the same conditions. The company targets domestic and overseas markets including Europe, China, the Middle East, and Southeast Asia for its products. The firm's primary customers are healthcare providers and diagnostic laboratories seeking rapid, on-site testing solutions. These segments value the portability and speed of the testers, which enable immediate diagnosis without laboratory processing. The cartridges complement the testers by providing consumable components for consistent diagnostic accuracy across various medical conditions. Precision Biosensor Inc. focuses on markets where demand for point-of-care diagnostics is growing, particularly in regions with expanding healthcare infrastructure. The company's product line addresses acute heart disease, metabolism, and inflammatory diseases, aligning with global health priorities. Sales in Europe, China, the Middle East, and Southeast Asia reflect the company's strategy to serve both developed and emerging healthcare systems. Precision Biosensor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Precision Biosensor stock

Inventory Turnover Ratio of Precision Biosensor is 1.52 in 2025.

Inventory Turnover Ratio of Precision Biosensor changed from 1.04 to 1.52, representing a 46.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Turnover Ratio Precision Biosensor since 2006 – with annual values, charts, and detailed analysis.

Inventory turnover measures how many times inventory is sold and replaced during a period. Higher turnover indicates efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory Turnover Ratio's Precision Biosensor with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Precision Biosensor

All Key Metrics — Precision Biosensor